AI assistant
HERBALIFE LTD. — Director's Dealing 2017
May 11, 2017
32337_dirs_2017-05-11_a28af94a-84d2-4b73-a330-e8120538a2a4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HERBALIFE LTD. (HLF)
CIK: 0001180262
Period of Report: 2017-05-09
Reporting Person: Aspauza Jossie (VP, SAM/CAM)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-05-09 | Common Stock | M | 3600 | $20.14 | Acquired | 5848 | Direct |
| 2017-05-09 | Common Stock | D | 996 | $72.81 | Disposed | 4852 | Direct |
| 2017-05-09 | Common Stock | F | 782 | $72.81 | Disposed | 4070 | Direct |
| 2017-05-09 | Common Stock | M | 600 | $21.57 | Acquired | 4670 | Direct |
| 2017-05-09 | Common Stock | D | 178 | $72.81 | Disposed | 4492 | Direct |
| 2017-05-09 | Common Stock | F | 127 | $72.81 | Disposed | 4365 | Direct |
| 2017-05-09 | Common Stock | M | 1840 | $6.82 | Acquired | 6205 | Direct |
| 2017-05-09 | Common Stock | D | 173 | $72.81 | Disposed | 6032 | Direct |
| 2017-05-09 | Common Stock | F | 501 | $72.81 | Disposed | 5531 | Direct |
| 2017-05-09 | Common Stock | M | 1854 | $22.94 | Acquired | 7385 | Direct |
| 2017-05-09 | Common Stock | D | 585 | $72.81 | Disposed | 6800 | Direct |
| 2017-05-09 | Common Stock | F | 381 | $72.81 | Disposed | 6419 | Direct |
| 2017-05-09 | Common Stock | M | 2257 | $53.29 | Acquired | 8676 | Direct |
| 2017-05-09 | Common Stock | D | 1652 | $72.81 | Disposed | 7024 | Direct |
| 2017-05-09 | Common Stock | F | 182 | $72.81 | Disposed | 6842 | Direct |
| 2017-05-09 | Common Stock | M | 5409 | $44.79 | Acquired | 12251 | Direct |
| 2017-05-09 | Common Stock | D | 3328 | $72.81 | Disposed | 8923 | Direct |
| 2017-05-09 | Common Stock | F | 625 | $72.81 | Disposed | 8298 | Direct |
| 2017-05-09 | Common Stock | M | 453 | $48.39 | Acquired | 8751 | Direct |
| 2017-05-09 | Common Stock | D | 302 | $72.81 | Disposed | 8449 | Direct |
| 2017-05-09 | Common Stock | F | 46 | $72.81 | Disposed | 8403 | Direct |
| 2017-05-09 | Common Stock | M | 3914 | $30.44 | Acquired | 12317 | Direct |
| 2017-05-09 | Common Stock | D | 1638 | $72.81 | Disposed | 10679 | Direct |
| 2017-05-09 | Common Stock | F | 684 | $72.81 | Disposed | 9995 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-05-09 | Stock Appreciation Rights | $20.14 | M | 3600 | Disposed | 2017-12-31 | Common Stock (3600) | Direct |
| 2017-05-09 | Stock Appreciation Rights | $21.57 | M | 600 | Disposed | 2018-02-28 | Common Stock (600) | Direct |
| 2017-05-09 | Stock Appreciation Rights | $6.82 | M | 1840 | Disposed | 2019-02-27 | Common Stock (1840) | Direct |
| 2017-05-09 | Stock Appreciation Rights | $22.94 | M | 1854 | Disposed | 2020-05-07 | Common Stock (1854) | Direct |
| 2017-05-09 | Stock Appreciation Rights | $53.29 | M | 2257 | Disposed | 2021-05-18 | Common Stock (2257) | Direct |
| 2017-05-09 | Stock Appreciation Rights | $44.79 | M | 5409 | Disposed | 2022-05-31 | Common Stock (5409) | Direct |
| 2017-05-09 | Stock Appreciation Rights | $48.39 | M | 453 | Disposed | 2022-09-01 | Common Stock (453) | Direct |
| 2017-05-09 | Stock Appreciation Rights | $30.44 | M | 3914 | Disposed | 2025-03-02 | Common Stock (3914) | Direct |
Footnotes
F1: The reporting person received 1,822 shares of common stock upon the net exercise of the 3,600 stock appreciation rights ("SARS"). The reporting person forfeited 996 shares of common stock underlying the SARS in payment of the exercise price and 782 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81.
F2: The reporting person received 295 shares of common stock upon the net exercise of the 600 SARs. The reporting person forfeited 178 shares of common stock underlying the SARS in payment of the exercise price and 127 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81.
F3: The reporting person received 1,166 shares of common stock upon the net exercise of the 1,840 SARs. The reporting person forfeited 173 shares of common stock underlying the SARS in payment of the exercise price and 501 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81.
F4: The reporting person received 888 shares of common stock upon the net exercise of the 1,854 SARs. The reporting person forfeited 585 shares of common stock underlying the SARS in payment of the exercise price and 381 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81.
F5: The reporting person received 423 shares of common stock upon the net exercise of the 2,257 SARs. The reporting person forfeited 1,652 shares of common stock underlying the SARS in payment of the exercise price and 182 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81.
F6: The reporting person received 1,456 shares of common stock upon the net exercise of the 5,409 SARs. The reporting person forfeited 3,328 shares of common stock underlying the SARS in payment of the exercise price and 625 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81.
F7: The reporting person received 105 shares of common stock upon the net exercise of the 453 SARS. The reporting person forfeited 302 shares of common stock underlying the SARS in payment of the exercise price and 46 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81.
F8: The reporting person received 1,592 shares of common stock upon the net exercise of the 3,914 SARs. The reporting person forfeited 1,638 shares of common stock underlying the SARS in payment of the exercise price and 684 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81.
F9: Consists of 9,787 stock appreciation rights granted under the Herbalife Ltd. 2014 Stock Incentive Plan of which 20% vested on March 2, 2016, 20% vested on March 2, 2017, and the remaining 60% will vest on March 2, 2018.